Fusion Pharm (Fusion Pharm) Debt-to-Revenue : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Fusion Pharm Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Fusion Pharm's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Fusion Pharm's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Fusion Pharm's annualized Revenue for the quarter that ended in . 20 was $0.00 Mil.

Fusion Pharm Debt-to-Revenue Historical Data

The historical data trend for Fusion Pharm's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusion Pharm Debt-to-Revenue Chart

Fusion Pharm Annual Data

Trend

Debt-to-Revenue

Fusion Pharm Quarterly Data

Debt-to-Revenue

Competitive Comparison of Fusion Pharm's Debt-to-Revenue

For the Pharmaceutical Retailers subindustry, Fusion Pharm's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fusion Pharm's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fusion Pharm's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fusion Pharm's Debt-to-Revenue falls into.

Fusion Pharm Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Fusion Pharm's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	N/A
	=	N/A

Fusion Pharm's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (. 20) Revenue data.

Fusion Pharm Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fusion Pharm's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusion Pharm (Fusion Pharm) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fusion Pharm Inc (OTCPK:FSPM) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

5850 East 58th Avenue, Unit F, Commerce City, CO, USA, 80022

Website

http://www.fusionpharminc.com

Fusion Pharm Inc is engaged in commercializing its patent pending PharmPods line of hydroponic cultivation systems. Its PharmPods are used for agricultural cultivation by urban farming companies and other specialty growers. Pharmpods are constructed of standard ISO steel shipping containers that are repurposed for use in indoor plant cultivation.

Fusion Pharm (Fusion Pharm) Headlines

No Headlines